Biochanin A Inhibits Colistin‐Induced Kidney Injury in Rats via Induction of Nrf2/HO‐1/NQO1 Axis

Colistin is a polymyxin glycopeptide antibiotic produced by bacteria known as colistinus, a Bacillus polymixa variant. Despite its deleterious side effects especially on the kidneys, the use of colistin was reconsidered because of its effectiveness against the multi-drug-resistant gram-negative bacilli. Biochanin A (BCA) is an isoflavone phytoestrogen compound with well-known anti-inflammatory, antioxidant and antiapoptotic activities. The current study aimed to investigate the nephroprotective activities of BCA against renal injury induced by colistin. BCA was administered in two dose levels (25 and 50 mg/kg, p.o.) and colistin was injected at a daily dose of 480,000 IU/kg, IP BCA administration guarded against colistin-induced kidney injury as it inhibited the increase in serum levels of creatinine, urea and cystatin C as well as histopathological alterations. In addition, BCA It exhibited antioxidant activities as it ameliorated the increase in renal content of malondialdehyde (MDA) and the reduction in the activities of, superoxide dismutase (SOD), and catalase (CAT). This was associated with modulation of Bax and Bcl-2 mRNA expression so as to antagonize colistin-induced apoptosis. Besides, BCA showed significant anti-inflammatory actions against colistin- induced increase in the immunoreactivity of interleukin-1 beta (IL-1β), cyclooxygenase-2 (COX-2), and tumor necrosis factor-alpha (TNF-α). Further, BCA enhanced immuno-expression of nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1), and NAD(P)H: quinone oxidoreductase (NQO1) in colistin-challenged animals. Also, BCA did not have any effects on the antibacterial activity of colistin. In conclusion, BCA significantly attenuates renal injury induced by the antibiotic colistin as evidenced by the reduced serum markers of kidney injury in rats. This can be credited, at least partially, to its antioxidant, antiapoptotic, anti-inflammatory activites as well as induction of Nrf2/HO-1/NQO1 axis.

Authors

Institutions

Publication Details

Journal
Journal of Biochemical and Molecular Toxicology
Published
2025-11-01
DOI
https://doi.org/10.1002/jbt.70616
Citations
1
Primary Topic
Chemotherapy-induced organ toxicity mitigation
Type
article
Field-Weighted Citation Impact
1.47
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biochanin A Inhibits Colistin‐Induced Kidney Injury in Rats via Induction of Nrf2/HO‐1/NQO1 Axis

Mohammed Z. Nasrullah
1 citations
Journal of Biochemical and Molecular Toxicology
Chemotherapy-induced organ toxicity mitigation
1.47
article

Biochanin A Inhibits Colistin‐Induced Kidney Injury in Rats via Induction of Nrf2/HO‐1/NQO1 Axis

Mohammed Z. Nasrullah
article en
1 citations

Abstract

Colistin is a polymyxin glycopeptide antibiotic produced by bacteria known as colistinus, a Bacillus polymixa variant. Despite its deleterious side effects especially on the kidneys, the use of colistin was reconsidered because of its effectiveness against the multi-drug-resistant gram-negative bacilli. Biochanin A (BCA) is an isoflavone phytoestrogen compound with well-known anti-inflammatory, antioxidant and antiapoptotic activities. The current study aimed to investigate the nephroprotective activities of BCA against renal injury induced by colistin. BCA was administered in two dose levels (25 and 50 mg/kg, p.o.) and colistin was injected at a daily dose of 480,000 IU/kg, IP BCA administration guarded against colistin-induced kidney injury as it inhibited the increase in serum levels of creatinine, urea and cystatin C as well as histopathological alterations. In addition, BCA It exhibited antioxidant activities as it ameliorated the increase in renal content of malondialdehyde (MDA) and the reduction in the activities of, superoxide dismutase (SOD), and catalase (CAT). This was associated with modulation of Bax and Bcl-2 mRNA expression so as to antagonize colistin-induced apoptosis. Besides, BCA showed significant anti-inflammatory actions against colistin- induced increase in the immunoreactivity of interleukin-1 beta (IL-1β), cyclooxygenase-2 (COX-2), and tumor necrosis factor-alpha (TNF-α). Further, BCA enhanced immuno-expression of nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1), and NAD(P)H: quinone oxidoreductase (NQO1) in colistin-challenged animals. Also, BCA did not have any effects on the antibacterial activity of colistin. In conclusion, BCA significantly attenuates renal injury induced by the antibiotic colistin as evidenced by the reduced serum markers of kidney injury in rats. This can be credited, at least partially, to its antioxidant, antiapoptotic, anti-inflammatory activites as well as induction of Nrf2/HO-1/NQO1 axis.

Journal of Biochemical and Molecular ToxicologyVol. 39(11)
King Abdulaziz University (SA)
Openalex Percentile: Top 14%
Chemotherapy-induced organ toxicity mitigation
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Biochanin A Inhibits Colistin‐Induced Kidney Injury in Rats via Induction of Nrf2/HO‐1/NQO1 Axis — Mohammed Z. Nasrullah · Journal of Biochemical and Molecular Toxicology (2025) | TGRS Research Map | TGRS